4//SEC Filing
Piazza Jonathan 4
Accession 0001209191-22-006437
CIK 0001671858other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:19 PM ET
Size
9.8 KB
Accession
0001209191-22-006437
Insider Transaction Report
Form 4
Piazza Jonathan
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+67,500→ 67,500 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (67,500 underlying) - Award
Common Stock
2022-02-01+11,250→ 25,534 total - Award
Stock Option (right to buy)
2022-02-01+42,750→ 42,750 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (42,750 underlying)
Footnotes (4)
- [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 2,054 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan (the "ESPP") on June 30, 2021 and 326 shares acquired under the ESPP on December 31, 2021.
- [F3]The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022.
- [F4]25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years.
Documents
Issuer
Silverback Therapeutics, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001831967
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:19 PM ET
- Size
- 9.8 KB